The Pathogenesis of Sepsis and Potential Therapeutic Targets

被引:561
|
作者
Huang, Min [1 ,2 ]
Cai, Shaoli [1 ,2 ]
Su, Jingqian [1 ,2 ]
机构
[1] Fujian Normal Univ, Coll Life Sci, Biomed Res Ctr South China, Fuzhou 350117, Fujian, Peoples R China
[2] Fujian Normal Univ, Key Labs Innate Immune Biol Fujian Prov, Fuzhou 350117, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
sepsis; pathogenesis; biomarkers; therapeutic drugs; SYSTEMIC INFLAMMATORY RESPONSE; DISSEMINATED INTRAVASCULAR COAGULATION; INTERNATIONAL CONSENSUS DEFINITIONS; HUMAN SOLUBLE THROMBOMODULIN; PATTERN-RECOGNITION RECEPTORS; ENDOPLASMIC-RETICULUM STRESS; POLYMYXIN-B HEMOPERFUSION; ORGAN FAILURE ASSESSMENT; CRITICALLY-ILL PATIENTS; NATURAL-KILLER-CELLS;
D O I
10.3390/ijms20215376
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sepsis is defined as "a life-threatening organ dysfunction caused by a host's dysfunctional response to infection". Although the treatment of sepsis has developed rapidly in the past few years, sepsis incidence and mortality in clinical treatment is still climbing. Moreover, because of the diverse manifestations of sepsis, clinicians continue to face severe challenges in the diagnosis, treatment, and management of patients with sepsis. Here, we review the recent development in our understanding regarding the cellular pathogenesis and the target of clinical diagnosis of sepsis, with the goal of enhancing the current understanding of sepsis. The present state of research on targeted therapeutic drugs is also elaborated upon to provide information for the treatment of sepsis.
引用
收藏
页数:31
相关论文
共 50 条
  • [1] The pathogenesis and potential therapeutic targets in sepsis
    Zhang, Wendan
    Jiang, Honghong
    Wu, Gaosong
    Huang, Pengli
    Wang, Haonan
    An, Huazhasng
    Liu, Sanhong
    Zhang, Weidong
    MEDCOMM, 2023, 4 (06):
  • [2] The immunopathology of sepsis and potential therapeutic targets
    van der Poll, Tom
    van de Veerdonk, Frank L.
    Scicluna, Brendon P.
    Netea, Mihai G.
    NATURE REVIEWS IMMUNOLOGY, 2017, 17 (07) : 407 - 420
  • [3] Potential therapeutic targets for sepsis in women
    Weniger, Maximilian
    D'Haese, Jan G.
    Angele, Martin K.
    Chaudry, Irshad H.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (11) : 1531 - 1543
  • [4] The immunopathology of sepsis and potential therapeutic targets
    Tom van der Poll
    Frank L. van de Veerdonk
    Brendon P. Scicluna
    Mihai G. Netea
    Nature Reviews Immunology, 2017, 17 : 407 - 420
  • [5] Sepsis and Oxidative Stress in the Newborn: From Pathogenesis to Novel Therapeutic Targets
    Poggi, Chiara
    Dani, Carlo
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [6] An update on pathogenesis of psoriatic arthritis and potential therapeutic targets
    Chimenti, Maria Sole
    Triggianese, Paola
    De Martino, Erica
    Conigliaro, Paola
    Fonti, Giulia Lavinia
    Sunzini, Flavia
    Caso, Francesco
    Perricone, Carlo
    Costa, Luisa
    Perricone, Roberto
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (08) : 823 - 836
  • [7] THERAPEUTIC TARGETS FOR SEPSIS
    Sorbera, L.
    Dulsat, C.
    Rosa, E.
    DRUGS OF THE FUTURE, 2009, 34 (09) : 765 - 770
  • [8] The Role and Mechanism of Pyroptosis and Potential Therapeutic Targets in Sepsis: A Review
    Zheng, Xiangtao
    Chen, Weiwei
    Gong, Fangchen
    Chen, Ying
    Chen, Erzhen
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [9] Apoptosis in sepsis: Mechanisms, clinical impact and potential therapeutic targets
    Ayala, Alfred
    Perl, Mario
    Venet, Fabienne
    Lomas-Neira, Joanne
    Swan, Ryan
    Chung, Chun-Shiang
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (19) : 1853 - 1859
  • [10] Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic Targets
    Li, Yupei
    Wan, Dingyuan
    Luo, Xinyao
    Song, Tao
    Wang, Yiran
    Yu, Qiao
    Jiang, Luojia
    Liao, Ruoxi
    Zhao, Weifeng
    Su, Baihai
    FRONTIERS IN IMMUNOLOGY, 2021, 12